Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
XanaCIDD: A Double-Blind, Randomized, Placebo Controlled, ParallelGroup Trial to Assess the Safety, Tolerability, and Efficacy of Xanamem® in Adults with Cognitive Impairment due to Depressive Disorder
Chen, Leo
(Primary Chief Investigator (PCI))
Gavrilidis, Emorfia
(Project Manager)
Department of Psychiatry (STM)
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
31/10/22
→
1/01/24
View all
View less
Keywords
Clinical trial
depression
Cognitive Impairment
Alzheimer disease